Elution of vancomycin and tobramycin bonded to vascular grafts

Journal of Chemotherapy

Volumn 11, Issue 1, 1999, Pages 46-49

  Leblebicioglu, Hakan ^a   Sencan, I ^a   Gunaydin, M ^a   Esen, S ^a   Eroglu, C ^a   Sunbul, M ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Prophylaxis; Tobramycin; Vancomycin; Vascular graft

Indexed keywords

TOBRAMYCIN; VANCOMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; BLOOD VESSEL GRAFT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ADSORPTION; DRUG DETERMINATION; DRUG EFFICACY; DRUG RELEASE; GRAFT INFECTION; HUMAN; IN VITRO STUDY; PLASMA; STAPHYLOCOCCUS AUREUS;

EID: 0033005070     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.1.46     Document Type: Article

References (13)

1. 1 Colburn MD, Moore WS, Chvapil M, Gelabert HA, Quinones-Baldrich WJ. Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections. J Vasc Surg 1992; 16: 651-60.
2. 2 Avramovic J, Fletcher JP. Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein-sealed Dacron graft in combination with parenteral cephalosporin. J Cardiovasc Surg 1992; 33: 70-4.
3. 3 Torsello G, Sandmann W, Gehrt A, Jungblut RM. In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results. J Vasc Surg 1993; 17(4): 768-73.
4. 4 Malassiney P, Goeau-Brissonniere O, Coggia M, Pechere JC. Rifampicin loading of vascular grafts. J Antimicrob Chemother 1996; 37: 1121-9.
5. 5 Leblebicioglu H, Saniç A, Günaydin M, Sencan I, Dabak N, Nas Y. In-vitro release of vancomycin and netilmicin from bone cement. Clin Microbiol Infect 1996; 1: 211-3.
6. 6 Joos B, Luthy R, Blaser J. Long-term accuracy of fluorescence polarization immunoassays for gentamicin, tobramycin, netilmicin and vancomycin. J Antimicrob Chemother 1989; 24(5): 797-803.
7. 7 Muhl E, Gatermann S, Iven H, Dendorfer A, Bruch HP. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model. Ann Vasc Surg 1996; 10: 244-53.
8. 8 Cunha BA. Vancomycin. Med Clin North Am 1995; 79(4): 817-31.
9. 9 Lortholary O, Tod M, Cohen Y, Petitjean O. Aminoglycosides. Med Clin North Am 1995; 79: 761-88.
10. 10 Lovering AM, White LO, MacGowan AP, Reeves DS. The elution binding characteristics of rifampicin for three commercially available protein-sealed vascular grafts. J Antimicrob Chemother 1996; 38: 599-604.
11. 11 McDougal EG, Burnham SJ, Johnson GJr. Rifampicin protection against experimental graft sepsis. J Vasc Surg 1986; 4: 5-7.
12. 12 Galdbart J, Branger C, Andreassian B, Lambert-Zechovsky N, Kitzis M. Elution of six antibiotics bonded to polyethylene vascular grafts sealed with three proteins. J Surg Res 1996; 66: 174-8.
13. 13 Pallasch T. Pharmacokinetic principles of antimicrobial therapy. Periodontology 2000 1996; 10: 5-11.